SCHEMBL4780752

SCHEMBL4780752

COc1cc(C2CC2)c2c(C#N)c(-c3ccc(NC(=O)OC(C)C)cc3)[nH]c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
CYP2C19 P33261 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
SIRT2 Q8IXJ6 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
LRRK2 Q5S007 1/20 0.36
KDR P35968 2/20 0.36
MET P08581 1/20 0.36
KDM4E B2RXH2 1/20 0.34
CHEK2 O96017 1/20 0.34
RXFP1 Q9HBX9 1/20 0.33
EGFR P00533 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
MMP14 P50281 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4839039 0.86 HPGD (0.35) NPC1CYP1A2CYP2D6CYP2C9HPGD
SCHEMBL4777353 0.79 MAOA (0.37) NPC1HPGDSMN1; SMN2KDM4EMAPT
SCHEMBL4774637 0.73 KCNQ2 (0.48) NPC1CYP1A2CYP2D6CYP2C9HPGD
SCHEMBL4776403 0.70 HPGD (0.56) NPC1CYP1A2CYP2D6CYP2C9HPGD
SCHEMBL2881403 0.70 HPGD (0.56) NPC1CYP1A2CYP2D6CYP2C9HPGD
SCHEMBL4771469 0.69 TLR9 (0.33) MAPT
SCHEMBL982697 0.68 NPC1 (0.48) NPC1CYP1A2CYP2D6CYP2C9HPGD
SCHEMBL4775583 0.67 PDE10A (0.35) HPGDRAB9ASMN1; SMN2KDM4ERXFP1
SCHEMBL4779519 0.67 TLR9 (0.32)
SCHEMBL981985 0.67 SMN1; SMN2 (0.47) NPC1CYP1A2CYP2D6CYP2C9HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984332-A2 METHODS FOR TREATING HEPATITIS C PTC Therapeutics, Inc. (US) 2008-10-29 EP disclosed
EP-1979315-A2 METHODS FOR TREATING HEPATITIS C PTC Therapeutics, Inc. (US) 2008-10-15 EP disclosed
WO-2007084413-A2 METHODS FOR TREATING HEPATITIS C PTC THERAPEUTICS, INC. (US) 2007-07-26 WO disclosed
WO-2007084435-A2 METHODS FOR TREATING HEPATITIS C PTC THERAPEUTICS, INC. (US) 2007-07-26 WO disclosed